4th International Consensus Conference: Primary Systemic Treatment in the Management of Operable Breast Cancer: Toward the Rapid Assessment of Therapy EfficacyBOTTINI, Alberto; BERRUTI, Alfredo; GENERALI, Daniele et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, issn 1052-6773, 101 p.Conference Proceedings

Mechanisms of Resistance to HER2 Target TherapyTORTORA, Giampaolo.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 95-98, issn 1052-6773, 4 p.Conference Paper

Surrogate Markers for Targeted Therapy―Based Treatment Activity and EfficacyBIANCHINI, Giampaolo; GIANNI, Luca.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 91-94, issn 1052-6773, 4 p.Conference Paper

The Value of Genomic Analysis of Breast Cancer in Drug DevelopmentSZEKELY, Borbala; PUSZTAI, Lajos.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 60-62, issn 1052-6773, 3 p.Conference Paper

The Pathologic Complete Response Open Question in Primary TherapyMARCHIO, Caterina; SAPINO, Anna.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 86-90, issn 1052-6773, 5 p.Conference Paper

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast CancerCURIGLIANO, Giuseppe; GOLDHIRSCH, Aron.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 108-110, issn 1052-6773, 3 p.Conference Paper

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising StrategyMETZGER-FILHO, Otto; DE AZAMBUJA, Evandro.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 116-119, issn 1052-6773, 4 p.Conference Paper

kConFab: A Familial Breast Cancer Consortium Facilitating Research and Translational OncologyTHORNE, Heather; MITCHELL, Gillian; FOX, Stephen et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 79-81, issn 1052-6773, 3 p.Conference Paper

Metabolic bone disease induced by prostate cancer: Rationale for the use of bisphosphonatesBERRUTI, Alfredo; DOGLIOTTI, Luigi; TUCCI, Marcello et al.The Journal of urology. 2001, Vol 166, Num 6, pp 2023-2031, issn 0022-5347Article

Biomarkers Predicting Clinical Benefit: Fact or Fiction?GUARNERI, Valentina; BARBIERI, Elena; CONTE, Pierfranco et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 63-66, issn 1052-6773, 4 p.Conference Paper

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and BiologicalUNTCH, Michael; VON MINCKWITZ, Gunter.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 138-141, issn 1052-6773, 4 p.Conference Paper

Biochemistry of breast cyst fluid : correlation with breast cancer risk, New York NY, December 5-6, 1988ANGELI, ALBERTO; BRADLOW, H. LEON; CHASALOW, FRED I et al.Annals of the New York Academy of Sciences. 1990, Vol 586, issn 0077-8923, 303 p.Conference Proceedings

Bridging the Gap Between Translational Research and Clinical ApplicationMILLER, William R; LARIONOV, Alexey A.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 134-137, issn 1052-6773, 4 p.Conference Paper

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer PatientsBERRUTI, Alfredo; GENERALI, Daniele; BERTAGLIA, Valentina et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 142-146, issn 1052-6773, 5 p.Conference Paper

Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial DesignGENERALI, Daniele; BERRUTI, Alfredo; BOTTINI, Alberto et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 67-70, issn 1052-6773, 4 p.Conference Paper

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Blood Oxygenation Level-Dependent Magnetic Resonance Imaging for the Assessment of Changes in Tumor Biology With TreatmentLI, Sonia P; PADHANI, Anwar R; MAKRIS, Andreas et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 103-107, issn 1052-6773, 5 p.Conference Paper

Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast CancerDOWSETT, Mitch; SMITH, Ian; SKENE, Tony et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 120-123, issn 1052-6773, 4 p.Conference Paper

Positron Emission Tomography and Neoadjuvant Therapy of Breast CancerCOCHET, Alexandre; GENERALI, Daniele; FOX, Stephen B et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 111-115, issn 1052-6773, 5 p.Conference Paper

Optimizing treatment for men with advanced prostate cancer : Expert recommendations and the multidisciplinary approachFITZPATRICK, John M; ANDERSON, John; HEIDENREICH, Axel et al.Critical reviews in oncology/hematology. 2008, Vol 68, issn 1040-8428, S9-S22, SUP1Article

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancerVON DER MAASE, Hans; SENGELOV, Lisa; ROBERTS, James T et al.Journal of clinical oncology. 2005, Vol 23, Num 21, pp 4602-4608, issn 0732-183X, 7 p.Article

Assessing Early Therapeutic Response to Bevacizumab in Primary Breast Cancer Using Magnetic Resonance Imaging and Gene Expression ProfilesMEHTA, Shaveta; HUGHES, Nicholas P; HARRIS, Adrian L et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 71-74, issn 1052-6773, 4 p.Conference Paper

Thymidylate Synthase Expression in Gastroenteropancreatic and Pulmonary Neuroendocrine TumorsCEPPI, Paolo; VOLANTE, Marco; FERRERO, Anna et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 1059-1064, issn 1078-0432, 6 p.Article

Adjuvant mitotane treatment for adrenocortical carcinomaTERZOLO, Massimo; ANGELI, Alberto; REIMONDO, Giuseppe et al.The New England journal of medicine. 2007, Vol 356, Num 23, pp 2372-2380, issn 0028-4793, 9 p.Article

Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapyTAMPELLINI, Marco; PIA BRIZZI, Maria; BITOSSI, Raffaella et al.Journal of cancer research and clinical oncology. 2007, Vol 133, Num 10, pp 783-785, issn 0171-5216, 3 p.Article

Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsBOTTINI, Alberto; GENERALI, Daniele; DIONISIO, Rossana et al.Journal of clinical oncology. 2006, Vol 24, Num 22, pp 3623-3628, issn 0732-183X, 6 p.Article